Did the FDA Just Threaten Glaxo's Future?

This episode of The Motley Fool's Market Checkup drills down on the day's hottest headlines and plays a game of investing chicken with the world's biggest biotech. Market Checkup gives a full examination of the potential new generic threat to a big-time blockbuster drug and looks at a study questioning the benefits of robotic surgery.

In this video, health-care analysts David Williamson and Max Macaluso discuss the FDA decision to lower the barrier to entry for Advair generics. The drug is critically important for GlaxoSmithKline. Watch and find out why Glaxo hadn't been anticipating generic competition for a few more years, what next generation COPD drugs it is counting on, and if this bad news combined with the $490 million Chinese bribery allegations makes the stock a stay-away.

Stick with dividend stocks
One of the best parts of owning big pharma stocks is their attractive dividends, but smart investors know the importance of diversifying -- seeking high-yielding stocks from multiple industries. The Motley Fool's special free report "Secure Your Future With 9 Rock-Solid Dividend Stocks" outlines the Fool's favorite dependable dividend-paying stocks across all sectors. Grab your free copy by clicking here.

Follow David on Twitter @MotleyDavid.


Read/Post Comments (0) | Recommend This Article (2)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2646404, ~/Articles/ArticleHandler.aspx, 9/18/2014 11:48:29 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement